Clal Insurance’s Pfizer PFE Stock Holding History

Clal Insurance’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.8M	Hold	2,234,000	–	–	0.24%	73
2026 Q1	$62.7M	Sell	2,234,000 -38,000	-2%	-$1.01M	0.38%	53
2025 Q4	$56.6M	Hold	2,272,000	–	–	0.36%	57
2025 Q3	$57.9M	Hold	2,272,000	–	–	0.44%	52
2025 Q2	$55.1M	Sell	2,272,000 -410	-0%	-$9.56K	0.54%	49
2025 Q1	$57.6M	Hold	2,272,410	–	–	0.6%	44
2024 Q4	$60.3M	Sell	2,272,410 -7,000	-0.3%	-$190K	0.54%	43
2024 Q3	$66M	Hold	2,279,410	–	–	0.58%	44
2024 Q2	$63.8M	Sell	2,279,410 -37,590	-2%	-$1.03M	0.67%	37
2024 Q1	$64.3M	Hold	2,317,000	–	–	0.72%	37
2023 Q4	$66.7M	Hold	2,317,000	–	–	0.87%	31
2023 Q3	$76.9M	Sell	2,317,000 -380,000	-14%	-$13.4M	1.07%	21
2023 Q2	$98.9M	Buy	2,697,000 +1,026,776	+61%	+$40M	1.18%	23
2023 Q1	$68.1M	Buy	1,670,224 +1,655,224	+11,035%	+$71.5M	1.02%	30
2022 Q4	$769K	Hold	15,000	–	–	0.01%	131
2022 Q3	$656K	Buy	+15,000	New	+$729K	0.01%	131
2016 Q3	–	Sell	-94,898	Closed	-$3.17M	–	109
2016 Q2	$3.17M	Sell	94,898 -187,629	-66%	-$5.99M	0.08%	75
2016 Q1	$7.95M	Sell	282,527 -961,657	-77%	-$27.5M	0.23%	59
2015 Q4	$38.1M	Buy	1,244,184 +69,564	+6%	+$2.19M	1.02%	28
2015 Q3	$35M	Hold	1,174,620	–	–	0.91%	26
2015 Q2	$37.4M	Hold	1,174,620	–	–	0.86%	29
2015 Q1	$38.8M	Sell	1,174,620 -70,470	-6%	-$2.24M	0.89%	28
2014 Q4	$36.8M	Buy	+1,245,090	New	+$35.7M	0.88%	34

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Clal Insurance's PFE Position: Q2 2026 in Review

Clal Insurance held its Pfizer (PFE) position steady in Q2 2026 at 2,234,000 shares worth $53.8M. The position accounts for 0.24% of the portfolio, ranked #73.

Clal Insurance first reported a position in PFE in Q4 2014 and has held it in 23 quarters since. The position peaked at $98.9M in Q2 2023. 2,832 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Clal Insurance held 2,234,000 shares of Pfizer worth $53.8M as of Q2 2026.
Clal Insurance left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.24% of Clal Insurance's portfolio in Q2 2026, its #73 holding.
Clal Insurance first reported a position in Pfizer in Q4 2014 and has held it in 23 quarters since.
Clal Insurance's Pfizer position peaked at $98.9M in Q2 2023.
2,832 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.